Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chris Boerner
Pharma
Bristol Myers CEO pledges to 'cast a broad net' in dealmaking
BMS completed $30 billion worth of deals in the past two years. Still, “business development remains a top priority,” CEO Chris Boerner said.
Angus Liu
Jan 12, 2026 4:28pm
Cobenfy delivers OK debut year as BMS works to ease nerves
Oct 30, 2025 11:19am
BMS touts commercial execution, reckons with clinical setbacks
Jul 31, 2025 11:10am
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
Bristol Myers CEO stays bullish on Cobenfy despite trial flop
Jun 12, 2025 12:43pm
Eyeing tariffs, BMS unveils 5-year, $40B US investment
May 6, 2025 10:30am
